Page last updated: 2024-09-03

gefitinib and yuanhuadine

gefitinib has been researched along with yuanhuadine in 2 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(yuanhuadine)
Trials
(yuanhuadine)
Recent Studies (post-2010) (yuanhuadine)
5,2315662,9191005

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, HJ; Hong, JY; Lee, HJ; Lee, SK; Park, HJ1
Bach, DH; Fan, YH; Hong, JY; Kim, D; Lee, SK; Luu, TT; Park, HJ1

Other Studies

2 other study(ies) available for gefitinib and yuanhuadine

ArticleYear
Growth inhibition of human lung cancer cells via down-regulation of epidermal growth factor receptor signaling by yuanhuadine, a daphnane diterpene from Daphne genkwa.
    Journal of natural products, 2011, Oct-28, Volume: 74, Issue:10

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Daphne; Disease Models, Animal; Diterpenes; Down-Regulation; ErbB Receptors; Female; Flowers; Humans; Mice; Mice, Nude; Molecular Structure; Terpenes

2011
AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells.
    Cell death & disease, 2019, 05-01, Volume: 10, Issue:5

    Topics: Acrylamides; Aniline Compounds; Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; ErbB Receptors; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Male; Mice, Nude; Protein Kinase Inhibitors; Proteolysis; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA, Small Interfering; Signal Transduction; Terpenes; Tumor Burden; Xenograft Model Antitumor Assays

2019